NYSE:ABBV
AbbVie Inc.
- Stock
industry
Drug Manufacturers / Generalexchange
New York Stock Exchangewebsite
www.abbvie.comipo date
Jan 02, 2013full time employees
50,000currency
USD
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus
founders
- S Nikhil Kumar
investments
Money Raised | Funding Round | Lead Investor | Announced Date | Organization Name |
---|---|---|---|---|
— | Corporate Round - Capsida | Yes | 23-02-2023 | Capsida |
$30M | Series C - Carisma Therapeutics | — | 21-09-2022 | Carisma Therapeutics |
— | Grant - The Institute for Family Health | — | 31-08-2021 | The Institute for Family Health |
— | Grant - The Night Ministry | — | 31-08-2021 | The Night Ministry |
— | Grant - Health Brigade | — | 31-08-2021 | Health Brigade |
— | Grant - MLK Health Center | — | 31-08-2021 | MLK Health Center |
— | Grant - Delaware Valley Community Health | — | 31-08-2021 | Delaware Valley Community Health |
— | Grant - Roanoke Chowan Community Health Center | — | 31-08-2021 | Roanoke Chowan Community Health Center |
— | Grant - Eskenazi Health | — | 31-08-2021 | Eskenazi Health |
— | Grant - Good Samaritan Health Center | — | 31-08-2021 | Good Samaritan Health Center |
acquisitions
Price | Acquiree Name | Announced Date | Transaction Name |
---|---|---|---|
— | ImmunoGen | 30-11-2023 | ImmunoGen acquired by AbbVie |
$255M | DJS Antibodies | 20-10-2022 | DJS Antibodies acquired by AbbVie |
$1B | Syndesi Therapeutics | 01-03-2022 | Syndesi Therapeutics acquired by AbbVie |
— | Mitokinin | 10-03-2021 | Mitokinin acquired by AbbVie |
— | Mavupharma | 15-07-2019 | Mavupharma acquired by AbbVie |
$63B | Allergan | 25-06-2019 | Allergan acquired by AbbVie |
$5.8B | Stemcentrx | 28-04-2016 | Stemcentrx acquired by AbbVie |
$21B | Pharmacyclics | 04-03-2015 | Pharmacyclics acquired by AbbVie |
— | ImmuVen | 01-01-2014 | ImmuVen acquired by AbbVie |
num employees
- 10001+
funding rounds
Money Raised | Announced Date | Lead Investors | Transaction Name | Number of Investors |
---|---|---|---|---|
$15B | 27-02-2024 | — | Post-IPO Debt - AbbVie | — |
$250K | 08-03-2023 | — | Post-IPO Equity - AbbVie | — |